3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neuroblastoma
3
Wilms Tumor
2
Sarcoma, Ewing
2
Sarcoma
2
Rhabdomyosarcoma
2
Rhabdoid Tumor
2
Osteosarcoma
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Medulloblastoma
2
Lymphoma, Non-Hodgkin
2
Histiocytosis, Langerhans-Cell
2
Hepatoblastoma
2
Glioma
2
Ependymoma
2
Xanthogranuloma, Juvenile
1
Thyroid Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Recurrence
1
Pheochromocytoma
1
Melanoma
1
Histiocytic Sarcoma
1
Hereditary Sensory and Autonomic Neuropathies
1
Head and Neck Neoplasms
1
Central Nervous System Neoplasms
1
Interventions
Cyclophosphamide
3
ruxolitinib
2
fludarabine phosphate
2
fludarabine
2
Methotrexate
2
thymoglobulin
1
siltuximab
1
duvelisib
1
cc-486
1
calaspargase pegol
1
blinatumomab
1
Whole-Body Irradiation
1
Valganciclovir
1
Transplantation
1
Thiotepa
1
Therapeutics
1
Thalidomide
1
Tacrolimus
1
Radiotherapy
1
Prednisone
1
Positron-Emission Tomography
1
Polymerase Chain Reaction
1
Peripheral Blood Stem Cell Transplantation
1
Mycophenolic Acid
1
Mesna
1
Melphalan
1
Interleukin-6
1
Ifosfamide
1
Granulocyte Colony-Stimulating Factor
1
Ganciclovir
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Large Granular Lymphocytic
×
tipifarnib
×
1 year
×
Clear all
No trials found.